Alitretinoin for cutaneous lupus erythematosus

Journal of the American Academy of Dermatology

Volumn 67, Issue 3, 2012, Pages

  Kuhn, Annegret ^a   Patsinakidis, Nikolaos ^a   Luger, Thomas ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; CALCINEURIN INHIBITOR; CHLOROQUINE; CYCLOPHOSPHAMIDE; DAPSONE; GLUCOCORTICOID; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOTRETINOIN; MEPACRINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; BLURRED VISION; CASE REPORT; DISCOID LUPUS ERYTHEMATOSUS; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FACE; FEMALE; HAND; HEADACHE; HUMAN; HYPERLIPIDEMIA; LETTER; MALE; PRIORITY JOURNAL; SCALP; SCAR; SKIN DEFECT; SKIN LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 84864986053     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.10.030     Document Type: Article

References (5)

1. S. Jessop, D.A. Whitelaw, and F.M. Delamere Drugs for discoid lupus erythematosus Cochrane Database Syst Rev 4 2009 CD002954
2. D. Bacman, A. Kuhn, and E. Ruzicka Dapsone and retinoids A. Kuhn, P. Lehmann, T. Ruzicka, Cutaneous lupus erythematosus 2004 Springer Verlag Heidelberg 373 391
3. A. Kuhn, V. Ruland, and G. Bonsmann Cutaneous lupus erythematosus: update of therapeutic options. Part I & Part II J Am Acad Dermatol 65 2011 e179-93 & e195-213
4. T. Ruzicka, C. Sommerburg, G. Goerz, P. Kind, and H. Mensing Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine Br J Dermatol 127 1992 513 518
5. T. Ruzicka, C.W. Lynde, G.B. Jemec, T. Diepgen, J. Berth-Jones, and P.J. Coenraads Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicenter trial Br J Dermatol 158 2008 808 817 (Pubitemid 351415754)